Closing Conditions

What generally occurs during the period between signing a definitive merger agreement and closing the transaction?

1. A.The parties satisfy the closing conditions specified in the definitive agreement, such as regulatory approvals and the shareholder voteCorrect. This is the core activity of the signing-to-closing period.
2. B.Nothing further happens, since the deal is fully complete once the agreement is signedWrong. Signing commits the parties to terms, but closing conditions must still be satisfied before the deal closes.
3. C.The buyer begins a brand-new due diligence process from scratchWrong. Comprehensive diligence occurs earlier in the process; the signing-to-closing period focuses on satisfying closing conditions, not starting diligence over.
4. D.The parties renegotiate the purchase price from the beginningWrong. The signed definitive agreement fixes the negotiated terms; price renegotiation is not the general activity of this period absent a specific triggering event.

Why: The period between signing and closing is primarily used to satisfy the closing conditions specified in the definitive agreement — such as required regulatory approvals and the shareholder vote — with the deal team monitoring progress toward satisfying each condition before the transaction can close.

Why is proxy statement/prospectus disclosure regarding the transaction prepared during the signing-to-closing period?

1. A.To inform shareholders of the material terms of the transaction so they can cast an informed voteCorrect. This is the core purpose of the proxy statement/prospectus disclosure at this stage.
2. B.To satisfy a purely optional marketing preference of the deal teamWrong. This disclosure is a substantive, disclosure-driven step tied to the shareholder vote, not an optional marketing choice.
3. C.To register the underwriters with FINRAWrong. Underwriter registration with FINRA is unrelated to proxy disclosure for a specific merger vote.
4. D.To finalize the buyer's internal syndicate short positionWrong. Syndicate short positions relate to a securities offering's stabilization mechanics, not an M&A shareholder vote disclosure.

Why: This disclosure informs shareholders of the material terms of the transaction so they can make an informed decision when voting on the deal — a step that must occur before the shareholder vote, which is itself typically one of the closing conditions.

A definitive merger agreement lists antitrust regulatory clearance as a closing condition. As the outside closing date approaches, that clearance has not yet been obtained. What is the deal team's appropriate role during this period?

1. A.Monitor the status of the unresolved closing condition and keep the parties informed as the outside date approachesCorrect. Monitoring and tracking unresolved closing conditions is exactly the deal team's role in this period.
2. B.Ignore the missing clearance and proceed to close on the originally scheduled date regardlessWrong. Closing conditions are contractual requirements; proceeding to close while a stated condition remains unsatisfied is not the appropriate default response.
3. C.Automatically terminate the agreement the moment the outside date is reached, with no further actionWrong. What happens at the outside date depends on the specific agreement's terms; automatic termination with no monitoring or communication is not the deal team's appropriate role.
4. D.File a new registration statement to replace the pending antitrust reviewWrong. A registration statement filing does not substitute for antitrust regulatory clearance, which is a separate review process.

Why: The deal team monitors the status of unresolved closing conditions — here, the pending antitrust clearance — tracking progress and keeping the parties informed, since the transaction cannot close until all stated conditions (or valid waivers of them) are satisfied.